help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 6, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0216
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/8/2967    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orio, F.
Right arrow Articles by Vigorito, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orio, F., Jr
Right arrow Articles by Vigorito, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Submitted on January 31, 2006
Accepted on May 26, 2006

Cardiopulmonary impairment in young women with polycystic ovary syndrome

Francesco Orio Jr*, Francesco Giallauria, Stefano Palomba, Teresa Cascella, Francesco Manguso, Laura Vuolo, Tiziana Russo, Achille Tolino, Gaetano Lombardi, Annamaria Colao, and Carlo Vigorito

Department of Molecular & Clinical Endocrinology and Oncology (F.O. Jr, T.C., L.V., G.L., A.C.), University "Federico II" Naples, Italy; Department of Clinical Medicine (F.G., C.V.), Cardiovascular and Immunological Sciences, Cardiac Rehabilitation Unit, University "Federico II" Naples, Italy; Department of Obstetrics and Gynecology (S.P., T.R.), University "Magna Graecia" of Catanzaro, Catanzaro, Italy; Gastroenterology Unit (F.M.), "Cardarelli" Hospital, Naples, Italy, Department of Obstetrics and Gynecology (A.T.), University "Federico II" Naples, Italy

* To whom correspondence should be addressed. E-mail: francescoorio{at}virgilio.it.

Context: Insulin resistance is a feature of polycystic ovary syndrome (PCOS) and it is related to mitochondrial function, particularly with maximal oxygen consumption (VO2max). At the moment no evaluation of cardiopulmonary functional capacity in young patients with PCOS has been performed.

Objective: To assess cardiopulmonary functional capacity in young PCOS overweight patients.

Design: Prospective baseline-controlled clinical study.

Setting: University "Federico II" of Naples, School of Medicine (Italy).

Patients: Forty-five PCOS patients matched with 45 healthy women mean age (21.3 ± 2.0 vs. 21.6 ± 1.9, yrs±SD, respectively) and body mass index (29.4 ± 3.6 vs. 29.0 ± 3.4, kg/m2±SD, respectively).

Mean Outcome Measures: Hormonal and metabolic pattern, and functional capacity by cardiopulmonary exercise testing evaluating: maximal oxygen consumption (VO2max), oxygen consumption at anaerobic threshold (VO2AT), and the maximal workload at peak exercise (Wattmax).

Results: VO2max (17.±3.7 vs. 26.8 ± 3.5, ml/Kg/min), VO2AT (13.9 ± 3.0 vs. 21.2 ± 3.8, ml/Kg/min), and Wattmax (101.3 ± 25.2 vs. 135 ± 22.6, W) resulted significantly (P < 0.001) reduced in PCOS subjects compared with healthy women. The multiple linear regression analysis showed that only homeostasis model assessment (HOMA) appears to have a strong negative linear relation with VO2max in PCOS. No relation was found in controls.

Conclusions: Our data firstly demonstrate a reduced cardiopulmonary functional capacity in young PCOS patients.


Key words: Cardiopulmonary exercise testing • maximal oxygen consumption • functional capacity • insulin resistance • hyperandrogenism • PCOS




This article has been cited by other articles:


Home page
DiabetesHome page
V. Skov, D. Glintborg, S. Knudsen, T. Jensen, T. A. Kruse, Q. Tan, K. Brusgaard, H. Beck-Nielsen, and K. Hojlund
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
Diabetes, September 1, 2007; 56(9): 2349 - 2355.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Vigorito, F. Giallauria, S. Palomba, T. Cascella, F. Manguso, R. Lucci, A. De Lorenzo, D. Tafuri, G. Lombardi, A. Colao, et al.
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1379 - 1384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society